Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.
Clinical trial NCT07392658 · RECRUITING
Trial details
- NCT number
- NCT07392658
- Sponsor
- Fondazione Ricerca Traslazionale
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-02
- Primary completion
- 2027-10-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.